Axonics, Inc. (AXNX)
NASDAQ: AXNX · IEX Real-Time Price · USD
68.49
+0.30 (0.44%)
At close: Jul 26, 2024, 4:00 PM
68.61
+0.12 (0.18%)
After-hours: Jul 26, 2024, 6:35 PM EDT
Axonics Revenue
Axonics had revenue of $91.41M in the quarter ending March 31, 2024, with 29.38% growth. This brings the company's revenue in the last twelve months to $387.14M, up 30.82% year-over-year. In the year 2023, Axonics had annual revenue of $366.38M with 33.86% growth.
Revenue (ttm)
$387.14M
Revenue Growth
+30.82%
P/S Ratio
9.03
Revenue / Employee
$485,744
Employees
797
Market Cap
3.49B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Prestige Consumer Healthcare | 1.13B |
GoodRx Holdings | 764.16M |
Denali Therapeutics | 295.39M |
Twist Bioscience | 277.49M |
Arcellx | 131.66M |
Alvotech | 114.39M |
Merus | 38.34M |
Arrowhead Pharmaceuticals | 35.47M |
AXNX News
- 2 months ago - Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia - Business Wire
- 3 months ago - Axonics Reports First Quarter 2024 Financial Results - Business Wire
- 3 months ago - Boston Scientific Announces Results for First Quarter 2024 - PRNewsWire
- 4 months ago - FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal - Reuters
- 4 months ago - Axonics Stockholders Approve Merger Agreement with Boston Scientific - Business Wire
- 4 months ago - Axonics Provides Update on Inter Partes Review Proceedings - Business Wire
- 4 months ago - Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System - Business Wire
- 5 months ago - Axonics Responds to ITC Action by Medtronic - Business Wire